Antioxidants and chronic disease: Evidence from observational epidemiology

Forum of Nutrition

Volumn 55, Issue , 2001, Pages 80-91

  Rimm, Eric B ^a   Stampfer, Meir J ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID;

CHRONIC DISEASE; CORONARY ARTERY DISEASE; CULTURAL FACTOR; EPIDEMIOLOGY; HUMAN; NEOPLASM; OBSERVATION; REVIEW; RISK FACTOR;

ANTIOXIDANTS; ASCORBIC ACID; CAROTENOIDS; CHRONIC DISEASE; CORONARY DISEASE; CROSS-CULTURAL COMPARISON; EPIDEMIOLOGIC METHODS; HUMANS; NEOPLASMS; OBSERVATION; RISK FACTORS; VITAMIN E;

EID: 56749133286     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (45)

1. Steinberg D: Antioxidants and atherosclerosis. A current assessment. Circulation 1991;84:1420-1425.
2. Sies H, Stahl W: Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995;62(suppl):1315S-1321S.
3. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ: Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992;12:554-562.
4. Boscoboinik D, Szewczyk A, Hensey C, Azzi A: Inhibition of cell proliferation by α-tocopherol: Role of protein kinase C. J Biol Chem 1991;266:6188-6194.
5. Retsky KL, Frei B: Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta 1995;1257:279-287.
6. Jialal I, Grundy SM: Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991;87:597-601.
7. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E: Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993;57(suppl):787S-797S.
8. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
9. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156-1162.
10. Losonczy KG, Harris TB, Havlik RJ: Vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly. Am J Clin Nutr 1996;64:190-196.
11. Kritchevsky SB, Shimakawa T, Tell GS, Dennis B, Carpenter M, Eckfeldt JH, Peacher-Ryan H, Heiss G: Dietary antioxidants and carotid artery wall thickness - The ARIC Study. Circulation 1995;92:2142-2150.
12. Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen SP: Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995;273:1849-1854.
13. Block G: Vitamin C and cancer prevention: The epidemiologic evidence. Am J Clin Nutr 1991;53(suppl):270S-282S.
14. World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, American Institute for Cancer Research, 1997.
15. Krinsky NI: Actions of carotenoids in biological systems. Annu Rev Nutr 1993;13:561-587.
16. Kardinaal AF, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, et al: Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC Study. Lancet 1993;342:1379-1384.
17. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ: Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-1161.
18. Block G, Patterson B, Subar A: Fruit, vegetables, and cancer prevention: A review of the epidemiologic evidence. Nutr Cancer 1992;18:1-29.
19. Rimm E, Ascherio A, Giovannucci E, Stampfer M, Willett W: Dietary fiber intake and risk of coronary heart disease among a large population of US men (abstract). Am J Epidemiol 1995;141:S17.
20. The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.
21. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S: Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-1155.
22. Hennekens CH, Buring JE, Manson JE, Stampfer MJ, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett WC, Peto R: Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-1149.
23. Rapola JM, Virtamo J, Haukka JK, Heinonen OP, Albanes D, Taylor PR, Huttunen JK: Effect of vitamin E and β-carotene on the incidence of angina pectoris - A randomized, double-blind, controlled trial. JAMA 1996;275:693-698.
24. Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, Mandel JS, Haile RW: Mortality associated with low plasma concentration of β-carotene and the effect of oral supplementation. JAMA 1996;2275:699-703.
25. Kostic D, White WS, Olson JA: Intestinal absorption, serum clearance, and interactions between lutein and β-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 1995;62:604-610.
26. Ribaya-Mercado JD, Ordovas JM, Russel RM: Effect of β-carotene supplementation on the concentrations and distribution of carotenoids, vitamin E, vitamin A, and cholesterol in plasma lipoprotein and non-lipoprotein fractions in healthy older women. Am Coll Nutr 1995;14:614-620.
27. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-1776.
28. Mills PK, Beeson WL, Phillips RL, Fraser GE: Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598-604.
29. Steiner M: Vitamin E enhances the benefits of aspirin in preventing or reducting the incidence of strokes (abstract). Second International Congress on Antioxidant Vitamins and Beta-Carotene in Disease Prevention, Berlin, Oct 10-12, 1994, p 22.
30. Stampfer MJ, Rimm EB: Epidemiologic evidence for vitamin E in the prevention of cardiovascular disease. Am J Clin Nutr 1995;62(suppl):1365S-1369S.
31. Kristenson M, Zieden B, Kucinskiene Z, Schafer Elinder L, Bergdahl B, Elwing B, Abaravicius A, Razinkoviene L, Calkauskas H, Olsson AG: Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross-sectional study of men aged 50. BMJ 1997;314:629-633.
32. Regnstrom J, Nilsson J, Moldeus P, Strom K, Bavenholm P, Tornvall P, Hamsten A: Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr 1996;63:377-385.
33. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A: Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-1189.
34. Meyer F, Bairati I, Dagenais GR: Lower ischemic heart disease incidence and mortality among vitamin supplement users. Can J Cardiol 1996;12:930-934.
35. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B,Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-1449.
36. Azen SP, Qian D, Mack WJ, Sevanian A, Selzer RH, Liu CR, Liu CH, Hodis HN: Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 1996;94:2369-2372.
37. Bonithon-Kopp C, Coudray C, Berr C, Touboul P, Feve JM, Favier A, Ducimetiere P: Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71: The Eva Study. Am J Clin Nutr 1997;65:121-127.
38. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786.
39. Knekt P: Vitamin E and smoking and the risk of lung cancer. Ann NY Acad Sci 1993;686:280-287.
40. Knekt P: Vitamin E and cancer: Epidemiology. Ann NY Acad Sci 1992;669:269-279.
41. The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: Design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10.
42. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW: Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 1993;2:335-339.
43. Knekt P: Serum vitamin E level and risk of female cancers. Int J Epidemiol 1988;17:281-286.
44. Meydani SN, Meydani M, Rall LC, Morrow F, Blumber JB: Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. Am J Clin Nutr 1994;60:704-709.
45. Bendich A, Machlin L: Safety of oral intake of vitamin E. Am J Clin Nutr 1988;48:612-619.